News

Against the backdrop of the global infusion therapy devices market projected to reach $13.43 billion in 2025, a new generation of sterile intravenous (IV) Administration Sets has emerged, integrating cutting-edge safety features and intelligent design to address critical challenges in clinical practice—from contamination risks to operational inefficiencies. Compliant with international standards including ISO 80369-7 and ISO 13485, these devices are set to elevate patient care and streamline workflows across hospitals, clinics, and home care settings.

Core Innovations: Safety at Every Stage of Infusion

At the heart of the new Iv Administration Sets is a multi-layered safety architecture designed to mitigate life-threatening risks. The3-part drip chamber features a transparent dome for real-time flow rate monitoring and an elastic bottom chamber, while a built-in micro-organism-tight air vent filter achieves >80% retention efficiency for 3µm particles, preventing air entrainment and bacterial contamination during venting. A breakthrough liquid lock system with an 8µm membrane acts as a fail-safe: if the fluid container empties, it automatically seals the tubing to avoid air embolism, eliminating manual monitoring gaps.

For drug delivery precision, the sets incorporate high-precision roller clamps with extended adjustment strokes (over 30mm) and clear drip counting—calibrated to 20 or 60 drops per mL—to ensure accurate dosage administration, critical for oncology and pediatric therapies. The Luer-Lock connectors (available in spinlock variants) feature a Back Check Valve that prevents blood backflow and inadvertent disconnection, whileneedle-free injection sites and Y-ports with grip plates enable safe, repeated drug admixtures without additional punctures.

Material and Sterility: Setting New Industry Benchmarks

Responding to growing demand for biocompatible solutions, the IV sets utilize DEHP-free, PVC-free tubing (optionally made of TPE or PUR) that eliminates chemical leaching risks while maintaining flexibility and kink resistance. Advanced sterilization processes—including gamma radiation and EO (ethylene oxide) treatment—ensure complete pyrogen elimination, with tamper-evident vacuum-sealed packaging that triggers color change if integrity is compromised during transport.

To combat catheter-related bloodstream infections (CRBSI), a leading cause of clinical complications, select models integrate antimicrobial-coated components (infused with silver ions or chlorhexidine) that inhibit colonization of Staphylococcus aureus and Escherichia coli, addressing the rise of multi-drug resistant strains (MRSA). The 15µm 药液过滤器 (15µm fluid filter) further intercepts particulate contaminants from rubber stoppers or drug admixtures, safeguarding vascular health for patients on long-term nutrition or chemotherapy.

Smart Integration and Clinical Versatility

Aligning with the digitalization trend in healthcare, the IV administration sets are engineered for seamless integration with infusion pumps (pressure-resistant up to 2 bar per ISO 8536-8) and remote monitoring systems. Wireless modules transmit real-time data—including flow rate anomalies, blockages, and air bubble detection—to central nurse stations, triggering instant audio-visual alerts and reducing response time to critical events.

Versatility is built into the design: customizable tubing lengths (150cm to 200cm) enhance patient mobility, while multi-lumen configurations support simultaneous drug infusion, blood sampling, and pressure monitoring, minimizing repeated punctures for ICU patients. All components are latex-free and BPA-free (except for select spinlock adapters), catering to patients with allergies and aligning with global regulatory requirements.

Compliance and Market Impact

Backed by CE, FDA, and GMP certifications, the IV administration sets adhere to stringent global standards, including the EU’s Medical Device Regulation (MDR) and CDC guidelines for infusion set replacement (24-hour maximum for pump-assisted use). Their launch comes as the global market for IV sets expands rapidly, driven by rising demand for personalized therapy and pandemic preparedness—trends that prioritize reliable, low-maintenance infusion solutions.

“These IV administration sets represent a paradigm shift in balancing safety, efficiency, and usability,” noted a clinical advisor. “By automating priming with prime stop caps that prevent leakage and contamination, and integrating fail-safes like air-stop filters, we’re reducing human error while protecting both patients and healthcare workers.”

As adoption accelerates, the new devices are poised to become a staple in infusion therapy, supporting the market’s projected 10.6% CAGR through 2029 by addressing unmet needs in infection control, precision, and operational agility.

The preparation and withdrawal of drugs and cytostatics present a high risk of bacterial and particulate contamination, as well as leakage and aerosol contamination. The more varied the preparations used, the safer and simpler their handling should be. Recently, a compact and handy Needle-Free System for the preparation and withdrawal of drugs has been developed to address these challenges.

The central element in this system is the spike. Effortless piercing, enabled by the special shaping of the spike tips, ensures safe handling when puncturing the caps of drug vials. An integral filter in the spike guarantees sterile aeration during withdrawal, and the protection cap on all spike products protects against damage and contamination. Additionally, this protection cap is designed to fit on the Male Luer-Lock of syringes, providing added contact-contamination protection.

For safe handling during drug dissolving, Male Luer-Lock syringes should always be used, allowing problem-free connection to the standard Luer-Lock connection or the lock mechanism of the spikes. During withdrawal, sterile aeration is achieved through the integral filter, and some spikes also feature an additional microfilter to prevent particulate contamination.

To meet diverse clinical needs, various types of spikes are available. A specialized microspike has been developed for use on very small medication ampoules (mini-ampoules), with a colored spike protection cap enabling simple identification. Some spikes are equipped with a patented lock mechanism, which renders the use of a separate cap superfluous and is ideal for frequent applications. Certain spikes also come with an additional integral 5 µm fluid filter that reliably prevents particulate contamination of solutions, while an integrated hydrophobic 0.20 µm filter in all spikes guarantees sterile aeration and venting, and reliably retains toxic aerosols during drug preparation.

The filling volumes of different spike types vary to accommodate different needs, ranging from 0.2 ml to 0.4 ml. Patient safety and therapeutic success are top priorities, and these spikes create the precondition of reliably preventing contamination of prepared drugs by microorganisms or particles (e.g., from rubber abrasion).

This needle-free drug preparation system is part of the broader category of medical transfer systems. The manufacturer of such systems has more than 60 years of research and development experience, with company-owned production facilities and sales companies around the world, ensuring efficient production, a tight-knit sales network, and first-class service for customers in the healthcare sector. The established quality management systems of the manufacturer comply with the provisions of EN ISO 13485, the Council Directive 93/42/EEC, and/or Regulation (EU) 2017/745, and have been certified by relevant, competent notified bodies.

In the medical field, accurate and safe dispensing process is the key link to ensure the treatment effect and safety of patients. In recent years, with the rapid development of medical technology, the requirements for dispensing tools have become higher and higher. With its innovative design and excellent performance, Medical Transfer Spike (Mini Spike) has brought more efficient and safe dispensing solutions to medical workers.

As a professional medical consumables manufacturer and professional supplier of tubing products, Rizhao Bigway Medical Device Co., Ltd. recently appeared at the 88th Shanghai CMEF International Medical Device Expo. At this exhibition, the company focused on displaying core product lines including medical accessories, infusion sets, infusion extension tubes, mini spikes, Insufflation Tubing (pneumoperitoneum tubing), and 3 way stopcock (three-way valve).

Horse infusion sets: special needs and challenges of large animal medical treatment As large livestock and working animals, horses have significantly different physiological structures from small pets